Todd Franklin Watanabe

CEO

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ARQT

Current role

CEO, Board Member

2017-01-01–present

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Arcutis Biotherapeutics, Inc. (ARQT)	President and Chief Executive Officer	$713,333	—	$2,067,190	$3,848,958	$579,584	$14,000	$7,223,065
2024	Arcutis Biotherapeutics, Inc. (ARQT)	President and Chief Executive Officer	$660,867	—	$1,405,630	$1,053,227	$549,841	$19,926	$3,689,491
2023	Arcutis Biotherapeutics, Inc. (ARQT)	President and Chief Executive Officer	$633,500	—	$1,384,250	$2,543,320	$354,127	$20,069	$4,935,266
2022	Arcutis Biotherapeutics, Inc. (ARQT)	President and Chief Executive Officer	$590,000	—	$1,252,803	$2,314,700	$407,100	$16,952	$4,581,555
2021	Arcutis Biotherapeutics, Inc. (ARQT)	President and Chief Executive Officer	$525,000	—	$1,060,788	$2,283,138	$393,750	$21,447	$4,284,123
2020	Arcutis Biotherapeutics, Inc. (ARQT)	President and Chief Executive Officer	$441,667	—	$800,690	$1,215,563	$281,563	$11,400	$2,750,883
2019	Arcutis Biotherapeutics, Inc. (ARQT)	President and Chief Executive Officer	$390,000	—	—	$580,546	$169,750	—	$1,140,296

No earnings-call appearances or filed executive changes recorded yet.